DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

Carmen Sapienza, Jean Lee, Jasmine Powell, Oluwatoyin Erinle, Faahud Yafai, James Reichert, Elias S. Siraj, Michael P. Madaio

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

We identified potential epigenetic biomarkers for chronic kidney disease progression by comparing site-specific DNA methylation levels in more than 14,000 genes between African American and Hispanic diabetes patients with end stage renal disease (ESRD) and diabetes patients without nephropathy. We identified 187 genes that are differentially methylated between the two groups on at least two CpG sites in each gene in DNA extracted from saliva. Of the 187 genes whose mean methylation levels differed between the two groups, 39 genes or closely related gene family members, have been reported to be involved in kidney development or diabetic nephropathy, per se, or have been associated with dialysis-induced changes in gene expression in peripheral blood cells. The fact that such a substantial fraction (21%) of the 187 candidate genes have been implicated previously through genome association or transcription profiling studies suggests strongly that the DNA methylation differences we observe are associated with disease predisposition and/ or treatment. The fact that these nephropathy and/or dialysis-associated differences between patients were identified in DNA extracted from saliva offers proof-of-principle that inter-individual epigenetic differences may prove useful as predictive biomarkers of disease susceptibility.

Original languageEnglish (US)
Pages (from-to)20-28
Number of pages9
JournalEpigenetics
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

DNA Methylation
Epigenomics
Chronic Kidney Failure
Genes
Saliva
Dialysis
Biomarkers
DNA
Disease Susceptibility
Diabetic Nephropathies
Chronic Renal Insufficiency
Hispanic Americans
Individuality
African Americans
Methylation
Disease Progression
Blood Cells
Genome
Kidney
Gene Expression

Keywords

  • Diabetic nephropathy
  • Dialysis
  • Dna methylation
  • End-stage renal disease

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. / Sapienza, Carmen; Lee, Jean; Powell, Jasmine; Erinle, Oluwatoyin; Yafai, Faahud; Reichert, James; Siraj, Elias S.; Madaio, Michael P.

In: Epigenetics, Vol. 6, No. 1, 01.01.2011, p. 20-28.

Research output: Contribution to journalArticle

Sapienza, C, Lee, J, Powell, J, Erinle, O, Yafai, F, Reichert, J, Siraj, ES & Madaio, MP 2011, 'DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy', Epigenetics, vol. 6, no. 1, pp. 20-28. https://doi.org/10.4161/epi.6.1.13362
Sapienza, Carmen ; Lee, Jean ; Powell, Jasmine ; Erinle, Oluwatoyin ; Yafai, Faahud ; Reichert, James ; Siraj, Elias S. ; Madaio, Michael P. / DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. In: Epigenetics. 2011 ; Vol. 6, No. 1. pp. 20-28.
@article{3bc9c497fdd14a379031734b3aaaa9fe,
title = "DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy",
abstract = "We identified potential epigenetic biomarkers for chronic kidney disease progression by comparing site-specific DNA methylation levels in more than 14,000 genes between African American and Hispanic diabetes patients with end stage renal disease (ESRD) and diabetes patients without nephropathy. We identified 187 genes that are differentially methylated between the two groups on at least two CpG sites in each gene in DNA extracted from saliva. Of the 187 genes whose mean methylation levels differed between the two groups, 39 genes or closely related gene family members, have been reported to be involved in kidney development or diabetic nephropathy, per se, or have been associated with dialysis-induced changes in gene expression in peripheral blood cells. The fact that such a substantial fraction (21{\%}) of the 187 candidate genes have been implicated previously through genome association or transcription profiling studies suggests strongly that the DNA methylation differences we observe are associated with disease predisposition and/ or treatment. The fact that these nephropathy and/or dialysis-associated differences between patients were identified in DNA extracted from saliva offers proof-of-principle that inter-individual epigenetic differences may prove useful as predictive biomarkers of disease susceptibility.",
keywords = "Diabetic nephropathy, Dialysis, Dna methylation, End-stage renal disease",
author = "Carmen Sapienza and Jean Lee and Jasmine Powell and Oluwatoyin Erinle and Faahud Yafai and James Reichert and Siraj, {Elias S.} and Madaio, {Michael P.}",
year = "2011",
month = "1",
day = "1",
doi = "10.4161/epi.6.1.13362",
language = "English (US)",
volume = "6",
pages = "20--28",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - DNA methylation profling identifes epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

AU - Sapienza, Carmen

AU - Lee, Jean

AU - Powell, Jasmine

AU - Erinle, Oluwatoyin

AU - Yafai, Faahud

AU - Reichert, James

AU - Siraj, Elias S.

AU - Madaio, Michael P.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - We identified potential epigenetic biomarkers for chronic kidney disease progression by comparing site-specific DNA methylation levels in more than 14,000 genes between African American and Hispanic diabetes patients with end stage renal disease (ESRD) and diabetes patients without nephropathy. We identified 187 genes that are differentially methylated between the two groups on at least two CpG sites in each gene in DNA extracted from saliva. Of the 187 genes whose mean methylation levels differed between the two groups, 39 genes or closely related gene family members, have been reported to be involved in kidney development or diabetic nephropathy, per se, or have been associated with dialysis-induced changes in gene expression in peripheral blood cells. The fact that such a substantial fraction (21%) of the 187 candidate genes have been implicated previously through genome association or transcription profiling studies suggests strongly that the DNA methylation differences we observe are associated with disease predisposition and/ or treatment. The fact that these nephropathy and/or dialysis-associated differences between patients were identified in DNA extracted from saliva offers proof-of-principle that inter-individual epigenetic differences may prove useful as predictive biomarkers of disease susceptibility.

AB - We identified potential epigenetic biomarkers for chronic kidney disease progression by comparing site-specific DNA methylation levels in more than 14,000 genes between African American and Hispanic diabetes patients with end stage renal disease (ESRD) and diabetes patients without nephropathy. We identified 187 genes that are differentially methylated between the two groups on at least two CpG sites in each gene in DNA extracted from saliva. Of the 187 genes whose mean methylation levels differed between the two groups, 39 genes or closely related gene family members, have been reported to be involved in kidney development or diabetic nephropathy, per se, or have been associated with dialysis-induced changes in gene expression in peripheral blood cells. The fact that such a substantial fraction (21%) of the 187 candidate genes have been implicated previously through genome association or transcription profiling studies suggests strongly that the DNA methylation differences we observe are associated with disease predisposition and/ or treatment. The fact that these nephropathy and/or dialysis-associated differences between patients were identified in DNA extracted from saliva offers proof-of-principle that inter-individual epigenetic differences may prove useful as predictive biomarkers of disease susceptibility.

KW - Diabetic nephropathy

KW - Dialysis

KW - Dna methylation

KW - End-stage renal disease

UR - http://www.scopus.com/inward/record.url?scp=78651247591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651247591&partnerID=8YFLogxK

U2 - 10.4161/epi.6.1.13362

DO - 10.4161/epi.6.1.13362

M3 - Article

C2 - 21150313

AN - SCOPUS:78651247591

VL - 6

SP - 20

EP - 28

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 1

ER -